ASCO 2025: Mieloma Múltiplo Refratário Ganha Nova Abordagem com Anticorpo Tri-Específico

Oncologia Brasil

Oncologia Brasil

11 jun, 2025

Hematologia
Oncologia
ASCO 2025
Mieloma
Oncologia Brasil

Escrito por Oncologia Brasil

Biografia

Oncologia Brasil is a specialized oncology platform with a team of experts covering all aspects of cancer treatment, providing relevant content and personalized solutions. Its goal is to meet the needs of healthcare professionals, pharmaceutical industries, and patients by offering reliable and up-to-date information to improve cancer understanding and management.